Detalhe da pesquisa
1.
Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities.
Oncologist
; 29(4): 289-302, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048782
2.
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
J Neurooncol
; 167(1): 145-154, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457090
3.
Impressive response to dabrafenib and trametinib plus silybin in a heavily pretreated IDH wild-type glioblastoma patient with BRAFV600E -mutant and SOX2 amplification.
Anticancer Drugs
; 34(1): 190-193, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35946547
4.
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.
J Neurooncol
; 163(2): 377-383, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37264256
5.
Prolonged benefit to pembrolizumab in anaplastic oligodendroglioma patient with mismatch repair deficiency: a case report.
Anticancer Drugs
; 32(2): 218-221, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33395066
6.
Eslicarbazepine in patients with brain tumor-related epilepsy: a single-center experience.
Int J Neurosci
; 131(9): 879-884, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32316814
7.
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab.
Anticancer Drugs
; 31(2): 199-204, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31702999
8.
Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study.
Int J Mol Sci
; 21(18)2020 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32937743
9.
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases.
Anticancer Drugs
; 29(9): 924-928, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30080691
10.
Glioblastoma and Internal Carotid Artery Calcium Score: A Possible Novel Prognostic Partnership?
J Clin Med
; 13(5)2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38592330
11.
Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain.
Front Pain Res (Lausanne)
; 4: 1256809, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37810433
12.
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series.
Expert Rev Endocrinol Metab
; 18(2): 181-198, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36876325
13.
Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis.
Eur J Cancer
; 191: 112959, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481865
14.
The role of radiation therapy and systemic treatments in meningioma: The present and the future.
Cancer Med
; 12(15): 16041-16053, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366279
15.
Antigen rapid diagnostic test monitoring for SARS-CoV-2 in asymptomatic and fully vaccinated cancer patients: Is it cost-effective?
Cancer Med
; 12(7): 7795-7800, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583551
16.
Spinal ependymoma in adults: from molecular advances to new treatment perspectives.
Front Oncol
; 13: 1301179, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38074692
17.
Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial.
Front Oncol
; 13: 1320710, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38162492
18.
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care.
Cancers (Basel)
; 14(23)2022 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497381
19.
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation.
Cancers (Basel)
; 14(16)2022 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010898
20.
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction.
Br J Radiol
; 95(1129): 20211018, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762492